Venkataraman Balasubramanian
Examiner (ID: 17374, Phone: (571)272-0662 , Office: P/1624 )
Most Active Art Unit | 1624 |
Art Unit(s) | 1624, 1611 |
Total Applications | 2999 |
Issued Applications | 2017 |
Pending Applications | 254 |
Abandoned Applications | 728 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 7151028
[patent_doc_number] => 20040171596
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-09-02
[patent_title] => 'Prodrugs for use as ophthalmic agents'
[patent_app_type] => new
[patent_app_number] => 10/731528
[patent_app_country] => US
[patent_app_date] => 2003-12-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 8695
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0171/20040171596.pdf
[firstpage_image] =>[orig_patent_app_number] => 10731528
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/731528 | Prodrugs for use as ophthalmic agents | Dec 8, 2003 | Issued |
Array
(
[id] => 5772162
[patent_doc_number] => 20050267302
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-12-01
[patent_title] => 'Eplerenone crystalline form exhibiting enhanced dissolution rate'
[patent_app_type] => utility
[patent_app_number] => 10/727681
[patent_app_country] => US
[patent_app_date] => 2003-12-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 92
[patent_figures_cnt] => 92
[patent_no_of_words] => 24997
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0267/20050267302.pdf
[firstpage_image] =>[orig_patent_app_number] => 10727681
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/727681 | Eplerenone crystalline form exhibiting enhanced dissolution rate | Dec 3, 2003 | Abandoned |
Array
(
[id] => 1040764
[patent_doc_number] => 06870062
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-03-22
[patent_title] => 'Thermally stable, anthraquinone colorants containing copolymerizable vinyl groups'
[patent_app_type] => utility
[patent_app_number] => 10/719883
[patent_app_country] => US
[patent_app_date] => 2003-11-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10450
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/870/06870062.pdf
[firstpage_image] =>[orig_patent_app_number] => 10719883
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/719883 | Thermally stable, anthraquinone colorants containing copolymerizable vinyl groups | Nov 20, 2003 | Issued |
Array
(
[id] => 7470892
[patent_doc_number] => 20040102637
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-05-27
[patent_title] => 'Thermally stable, anthraquinone colorants containing copolymerizable vinyl groups'
[patent_app_type] => new
[patent_app_number] => 10/719268
[patent_app_country] => US
[patent_app_date] => 2003-11-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10561
[patent_no_of_claims] => 53
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0102/20040102637.pdf
[firstpage_image] =>[orig_patent_app_number] => 10719268
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/719268 | Thermally stable, anthraquinone colorants containing copolymerizable vinyl groups | Nov 20, 2003 | Issued |
Array
(
[id] => 7474535
[patent_doc_number] => 20040122072
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-06-24
[patent_title] => 'Thermally stable, anthraquinone colorants containing copolymerizable vinyl groups'
[patent_app_type] => new
[patent_app_number] => 10/719427
[patent_app_country] => US
[patent_app_date] => 2003-11-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10557
[patent_no_of_claims] => 53
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0122/20040122072.pdf
[firstpage_image] =>[orig_patent_app_number] => 10719427
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/719427 | Thermally stable, anthraquinone colorants containing copolymerizable vinyl groups | Nov 20, 2003 | Issued |
Array
(
[id] => 7677145
[patent_doc_number] => 20040152681
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-08-05
[patent_title] => 'Steroid derivatives'
[patent_app_type] => new
[patent_app_number] => 10/705398
[patent_app_country] => US
[patent_app_date] => 2003-11-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9709
[patent_no_of_claims] => 68
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0152/20040152681.pdf
[firstpage_image] =>[orig_patent_app_number] => 10705398
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/705398 | Steroid derivatives | Nov 9, 2003 | Abandoned |
Array
(
[id] => 7238724
[patent_doc_number] => 20040157814
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-08-12
[patent_title] => '6, 7-Oxygenated steroids and uses related thereto'
[patent_app_type] => new
[patent_app_number] => 10/703153
[patent_app_country] => US
[patent_app_date] => 2003-11-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 51542
[patent_no_of_claims] => 76
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0157/20040157814.pdf
[firstpage_image] =>[orig_patent_app_number] => 10703153
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/703153 | 6,7-Oxygenated steroids and uses related thereto | Nov 5, 2003 | Issued |
Array
(
[id] => 699793
[patent_doc_number] => 07067682
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-06-27
[patent_title] => '6,7-Oxygenated steroids and uses related thereto'
[patent_app_type] => utility
[patent_app_number] => 10/703155
[patent_app_country] => US
[patent_app_date] => 2003-11-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 50862
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 75
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/067/07067682.pdf
[firstpage_image] =>[orig_patent_app_number] => 10703155
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/703155 | 6,7-Oxygenated steroids and uses related thereto | Nov 5, 2003 | Issued |
Array
(
[id] => 1046853
[patent_doc_number] => 06864248
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-03-08
[patent_title] => 'Androgenic steroid compounds and a method of making and using the same'
[patent_app_type] => utility
[patent_app_number] => 10/699885
[patent_app_country] => US
[patent_app_date] => 2003-11-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9553
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/864/06864248.pdf
[firstpage_image] =>[orig_patent_app_number] => 10699885
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/699885 | Androgenic steroid compounds and a method of making and using the same | Nov 3, 2003 | Issued |
Array
(
[id] => 7290998
[patent_doc_number] => 20040110739
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-06-10
[patent_title] => 'PHOTOCHEMOTHERAPEUTIC METHOD USING 5-AMINOLEVULINIC ACID AND OTHER PRECURSORS OF ENDOGENOUS PORPHYRINS'
[patent_app_type] => new
[patent_app_number] => 10/605826
[patent_app_country] => US
[patent_app_date] => 2003-10-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 10600
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0110/20040110739.pdf
[firstpage_image] =>[orig_patent_app_number] => 10605826
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/605826 | PHOTOCHEMOTHERAPEUTIC METHOD USING 5-AMINOLEVULINIC ACID AND OTHER PRECURSORS OF ENDOGENOUS PORPHYRINS | Oct 28, 2003 | Abandoned |
Array
(
[id] => 5875256
[patent_doc_number] => 20060166952
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-07-27
[patent_title] => '2\"oxo-voruscharin and derivatives thereof'
[patent_app_type] => utility
[patent_app_number] => 10/530904
[patent_app_country] => US
[patent_app_date] => 2003-10-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 22153
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0166/20060166952.pdf
[firstpage_image] =>[orig_patent_app_number] => 10530904
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/530904 | 2″ oxo-voruscharin and derivatives thereof | Oct 8, 2003 | Issued |
Array
(
[id] => 7276360
[patent_doc_number] => 20040235811
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-11-25
[patent_title] => 'Fatty acid modified forms of glucocorticoids'
[patent_app_type] => new
[patent_app_number] => 10/681614
[patent_app_country] => US
[patent_app_date] => 2003-10-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4421
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0235/20040235811.pdf
[firstpage_image] =>[orig_patent_app_number] => 10681614
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/681614 | Fatty acid modified forms of glucocorticoids | Oct 7, 2003 | Abandoned |
Array
(
[id] => 7310528
[patent_doc_number] => 20040142915
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-07-22
[patent_title] => '11beta-short chain substituted estradiol analogs and their use in the treatment of menopausal symptoms and estrogen sensitive cancer'
[patent_app_type] => new
[patent_app_number] => 10/676287
[patent_app_country] => US
[patent_app_date] => 2003-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 8978
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0142/20040142915.pdf
[firstpage_image] =>[orig_patent_app_number] => 10676287
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/676287 | 11 beta-short chain substituted estradiol analogs and their use in the treatment of menopausal symptoms and estrogen sensitive cancer | Sep 30, 2003 | Issued |
Array
(
[id] => 7270622
[patent_doc_number] => 20040059140
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-03-25
[patent_title] => '14(15)-unsaturated 15- and/or 16-substituted androgens with mixed androgen-progrestational profile'
[patent_app_type] => new
[patent_app_number] => 10/450693
[patent_app_country] => US
[patent_app_date] => 2003-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7493
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0059/20040059140.pdf
[firstpage_image] =>[orig_patent_app_number] => 10450693
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/450693 | 14(15)-unsaturated 15- and/or 16-substituted androgens with mixed androgen-progrestational profile | Sep 30, 2003 | Abandoned |
Array
(
[id] => 7674645
[patent_doc_number] => 20040127473
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-07-01
[patent_title] => 'Compound'
[patent_app_type] => new
[patent_app_number] => 10/674892
[patent_app_country] => US
[patent_app_date] => 2003-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 17833
[patent_no_of_claims] => 64
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0127/20040127473.pdf
[firstpage_image] =>[orig_patent_app_number] => 10674892
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/674892 | Compound | Sep 29, 2003 | Abandoned |
Array
(
[id] => 7453216
[patent_doc_number] => 20040067917
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-04-08
[patent_title] => 'Processes for preparation of 9, 11-epoxy steroids and intermediates useful therein'
[patent_app_type] => new
[patent_app_number] => 10/672680
[patent_app_country] => US
[patent_app_date] => 2003-09-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 47349
[patent_no_of_claims] => 65
[patent_no_of_ind_claims] => 24
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0067/20040067917.pdf
[firstpage_image] =>[orig_patent_app_number] => 10672680
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/672680 | Processes for preparation of 9,11-epoxy steroids and intermediates useful therein | Sep 25, 2003 | Issued |
Array
(
[id] => 7378487
[patent_doc_number] => 20040028610
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-02-12
[patent_title] => 'Method of increasing the sensitivity of mammography'
[patent_app_type] => new
[patent_app_number] => 10/381824
[patent_app_country] => US
[patent_app_date] => 2003-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3486
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0028/20040028610.pdf
[firstpage_image] =>[orig_patent_app_number] => 10381824
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/381824 | Method of increasing the sensitivity of mammography | Sep 21, 2003 | Abandoned |
Array
(
[id] => 390330
[patent_doc_number] => 07300926
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-11-27
[patent_title] => 'Steroidal quinols and their use for estrogen replacement therapy'
[patent_app_type] => utility
[patent_app_number] => 10/666191
[patent_app_country] => US
[patent_app_date] => 2003-09-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 6
[patent_no_of_words] => 6734
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/300/07300926.pdf
[firstpage_image] =>[orig_patent_app_number] => 10666191
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/666191 | Steroidal quinols and their use for estrogen replacement therapy | Sep 16, 2003 | Issued |
Array
(
[id] => 7281300
[patent_doc_number] => 20040063677
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-04-01
[patent_title] => 'Methods of treating disorders using lipophilic derivatives'
[patent_app_type] => new
[patent_app_number] => 10/662441
[patent_app_country] => US
[patent_app_date] => 2003-09-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 18579
[patent_no_of_claims] => 55
[patent_no_of_ind_claims] => 32
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0063/20040063677.pdf
[firstpage_image] =>[orig_patent_app_number] => 10662441
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/662441 | Methods of treating disorders using lipophilic derivatives | Sep 15, 2003 | Abandoned |
Array
(
[id] => 7187988
[patent_doc_number] => 20050192262
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-01
[patent_title] => 'Treatment of tumours'
[patent_app_type] => utility
[patent_app_number] => 10/658125
[patent_app_country] => US
[patent_app_date] => 2003-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 14158
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0192/20050192262.pdf
[firstpage_image] =>[orig_patent_app_number] => 10658125
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/658125 | Treatment of tumours | Sep 8, 2003 | Abandoned |